Lectures & Presentations

Novelties in quantitative Thin Layer Chromatography.
Analytical section
Duphar, 1986.

Particle size analysis.
Analytical section
Duphar, 1987.

Particle characterisation.
Formulation Development, Chemical Development and Chemical Technology Departments
Duphar, 1988.

Particle size analysis of pharmaceuticals, pesticides and LC stationary phases.
Syllabus PAON-cursus "Particle Size Measurement", 1989. Veldhoven (PAON).

Validation of chromatography methods in bioanalysis.
Analytical section
Duphar, April 1991.

Method validation. 
DARQA
Zeist, May 1997.

Bioanalysis in general.
Students Biomedical Sciences
Solvay, October 1998.

Contracting Out. 
Pharmaceutical Analysis and Development Departments
Solvay, October 1998.

Validation bioanalysis for toxicokinetics. 
BioAnalysis en Drug Safety Departments
Solvay, November 1998.

Bioanalysis and Pharmacokinetics
Students Biomedical Sciences
Solvay, October 1999.

Bioanalysis and Pharmacokinetics
Students Biomedical Sciences
Solvay, October 2000.

Quality systems in bioanalysis
PhD Students Pharmacy & Medicine
Solvay, June 2001

Bioanalysis: General overview
Scientific Exchange: Pharmacology, Drug Safety, BioAnalysis
Solvay, November 2001

Quality systems in bioanalysis
PhD Students Pharmacy & Medicine
Solvay Pharmaceuticls, May 2002

Gewinnung von Proben: Stabilität während Plasma-/Serumgewinnung (Sampling: stability during plasma-/serum collection)
A&M Workshop 2004: Biovalidierung nach “Shah”. Unsetzung der FDA “Guidance for Industry”
Bedburg-Kaster, Germany, May 2004

Outsourcing: Challenges & Successes
3rd Annual Bioanalysis in Clinical Research
Olympia Conference Centre, London, UK, February 2008

EBF: ISR – MIST – EMEA
3rd Calibration and Validation Group Workshop on Recent Issues in Regulated Bioanalysis
Calibration and Validation Group, Montreal, Canada, April 2009

EBF survey: Quality systems in macromolecule analysis
2009 AAPS National Biotechnology Conference
Seattle, WA, USA, June 2009

EBF Perspective on the New EMA Guidelines on Bioanalytical Method Validation (BMV) and input on global BMV harmonization
The 4th Workshop on Recent Issues in Regulated Bioanalysis of the Canadian LC-MS/MS group (CVG)
Montreal, QC, Canada, April 2010

New EBF organsiation and how CROs may fit in there
EBF-CRO meeting
Brussels, Belgium, October 2010

Building the Global Bioanalysis Consortium – Working towards a functional globally acceptable and harmonized guideline on bioanalytical method validation
2010 FABIAN meeting “Doping opnieuw geanalyseerd”
Utrecht, Netherlands, November 2010

Update on EBF organisation
EBF 3rd open meeting “From Challenges to Solutions”
Barcelona, Spain, December 2010

Building the Global Bioanalysis Consortium – Working towards a functional globally acceptable and harmonized guideline on bioanalytical method validation
SoFAQ International Seminar – Quality Assurance and Electronic Data
Paris, France, December 2010

Learning From Issues in Assay Cross-Validation / Method Transfers
The 5th Bioanalysis Workshop (CVG)
Montreal, Canada, April 2011

How to Implement the EMA Guideline on Bioanalytical Method Validation
EBF 4th open symposium “Less is More”
Barcelona, Spain, November 2011

The EMA Bioanalytical Method Validation Guideline: process, history, discussions and evaluation of its content.
JBF 2nd Symposium
Tokyo, Japan, March 2012

Historic perspective on the evolution of Regulated Bioanalysis
Acbio 1st Bioanalytical Symposium
Sao Paulo, Brazil, May 2012

The EMA Bioanalytical Method Validation Guideline: process, history, discussions and evaluation of its content.
Acbio 1st Bioanalytical Symposium
Sao Paulo, Brazil, May 2012

Feedback from GBC Harmonization team leaders Face to Face (March 2012)
EBF 3rd Focus Meeting “Hatching”
Brussels, Belgium, June 2012

The EMA Bioanalytical Method Validation Guideline: process, history, discussions and evaluation of its content.
EBF 5th Open Symposium “Old Battles, New Horizons”
Barcelona, Spain, November 2012

Global Regulatory Issues: one BA method, one validation, one report …
14th Land O’Lakes Bioanalytical Conference
Madison WI, USA, July 2013

Global Regulatory Issues: one BA method, one validation, one report …
BioanalysisZone Expert Panel Presentations 
http://www.bioanalysis-zone.com/media-centre/land-o-lakes-global-regulatory-issues-peter-van-amsterdam-abbott

Global Regulatory Issues: one BA method, one validation, one report …
International Reid Bioanalytical Forum
Guildford, United Kingdom, September 2013

Successful treatment of maldigestion due to Pancreatic Exocrine Insufficiency: diagnosis, clinical picture and the challenges of measurements involved
EBF 6th Open Symposium “Moving forward together”
Barcelona, Spain, November 2013

Lab manuals for PK sampling: a Study Monitor perspective
EBF Focus Workshop “Standardised Lab Manual for bioanalytical support in clinical studies”
Brussels, Belgium, February 2014

Evaluating EMA and FDA guidance on bioanalytical method validation
10th Bioavailability / Bioequivalence, Dissolution and Biowaivers
Budapest, Hungary, April 2014

Introduction to the CTA & NDA process in China
EBF/CBF China Days
Berlin, Germany, September 2014

GCP meets GLP – The sponsor’s perspective
DARQA Theme Day “GCP meets GLP”
Utrecht, Netherlands, January 2015

All for one, one for all - The Chinese guideline in perspective to other guidelines
CPSA Shanghai 2015 “Connecting the dots”
Shanghai, China, April 2015

No comments: